Victrex plc (LON:VCT – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 640.96 and traded as high as GBX 651. Victrex shares last traded at GBX 637, with a volume of 215,830 shares trading hands.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on VCT shares. Canaccord Genuity Group cut Victrex to a “buy” rating and set a GBX 725 price objective for the company. in a research note on Friday, May 15th. UBS Group reiterated a “sell” rating and issued a GBX 575 price objective on shares of Victrex in a research note on Monday, May 11th. JPMorgan Chase & Co. reduced their price objective on Victrex from GBX 725 to GBX 625 and set a “buy” rating for the company in a research note on Wednesday, March 18th. Finally, Jefferies Financial Group reduced their price objective on Victrex from GBX 675 to GBX 595 and set a “hold” rating for the company in a research note on Tuesday, May 12th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of GBX 702.86.
View Our Latest Analysis on VCT
Victrex Price Performance
Victrex (LON:VCT – Get Free Report) last released its quarterly earnings results on Monday, May 11th. The company reported GBX 17.20 EPS for the quarter. Victrex had a negative return on equity of 4.95% and a negative net margin of 6.70%.The business had revenue of £147.10 million during the quarter. Sell-side analysts expect that Victrex plc will post 73.1078905 EPS for the current fiscal year.
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Featured Articles
- Five stocks we like better than Victrex
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
